The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services (HHS) announces its eleventh settlement of an enforcement action in its HIPAA Right of Access Initiative. OCR announced this initiative as an enforcement priority in 2019 to support individuals’ right to timely access to their health records at a reasonable ...
Citing patient safety, the agency says it has “significant concerns” regarding the electronic health record vendor’s compliance with its obligation under a 2017 Corporate Integrity Agreement. Powered by WPeMatico
The huge health system reduced medication clinical decision support alerts by 6.2 million over the course of a year. Powered by WPeMatico
Ed Simcox, who left HHS in February, says it’s time to create an information-sharing system that leverages modern technologies – before the next crisis hits. Powered by WPeMatico
Now available in public preview, the offerings are designed to help organizations and individuals pull clinically-relevant insights from large volumes of free text housed in medical records. Powered by WPeMatico
The report surveyed 2,000 people on their attitudes towards advancing technology in health and social care and contains government recommendations. Powered by WPeMatico
The filing follows Mayo Clinic’s announcement that a former employee had inappropriately accessed the information of more than 1,600 patients. Powered by WPeMatico
As a result of a rapid response plan, COPE Community Services continued to deliver healthcare at a pre-pandemic rate, and patients were seen with little disruption. Powered by WPeMatico
Both will work together to accelerate the growth of transformational healthcare companies across markets in the Middle East and North African, and the Association of South-East Asian Nations. Powered by WPeMatico
The U.S. Department of Health and Human Services today announced plans to allocate initial doses of Eli Lilly and Company’s investigational monoclonal antibody therapeutic, bamlanivimab, which received emergency use authorization from the U.S. Food and Drug Administration November 9 for the treatment of non-hospitalized patients with mild or moderate confirmed cases of COVID-19. On October ...